Interventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature - 2001-2007

Christine Y Lu, Dennis Ross-Degnan, Stephen B Soumerai, Sallie-Anne Pearson, Christine Y Lu, Dennis Ross-Degnan, Stephen B Soumerai, Sallie-Anne Pearson

Abstract

Background: Managed care organizations use a variety of strategies to reduce the cost and improve the quality of medication use. The effectiveness of such policies is not well understood. The objective of this research was to update a previous systematic review of interventions, published between 1966 and 2001, to improve the quality and efficiency of medication use in the US managed care setting.

Methods: We searched MEDLINE and EMBASE for publications from July 2001 to January 2007 describing interventions targeting drug use conducted in the US managed care setting. We categorized studies by intervention type and adequacy of research design using commonly accepted criteria. We summarized the outcomes of well-controlled strategies and documented the significance and magnitude of effects for key study outcomes.

Results: We identified 164 papers published during the six-year period. Predominant strategies were: educational interventions (n = 20, including dissemination of educational materials, and group or one-to-one educational outreach); monitoring and feedback (n = 22, including audit/feedback and computerized monitoring); formulary interventions (n = 66, including tiered formulary and patient copayment); collaborative care involving pharmacists (n = 15); and disease management with pharmacotherapy as a primary focus (n = 41, including care for depression, asthma, and peptic ulcer disease). Overall, 51 studies met minimum criteria for methodological adequacy. Effective interventions included one-to-one academic detailing, computerized alerts and reminders, pharmacist-led collaborative care, and multifaceted disease management. Further, changes in formulary tier-design and related increases in copayments were associated with reductions in medication use and increased out-of-pocket spending by patients. The dissemination of educational materials alone had little or no impact, while the impact of group education was inconclusive.

Conclusion: There is good evidence for the effectiveness of several strategies in changing drug use in the managed care environment. However, little is known about the cost-effectiveness of these interventions. Computerized alerts showed promise in improving short-term outcomes but little is known about longer-term outcomes. Few well-designed, published studies have assessed the potential negative clinical effects of formulary-related interventions despite their widespread use. However, some evidence suggests increases in cost sharing reduce access to essential medicines for chronic illness.

References

    1. Health Care Marketplace Project . Trends and Indicators in the changing health care marketplace. Washington, DC, Henry J. Kaiser Family Foundation; 2005.
    1. Kaiser Family Foundation . Prescription drug trends. Washington, DC, Henry J. Kaiser Family Foundation; 2007.
    1. Lexchin J. Effects of restrictive formularies in the ambulatory care setting. American Journal of Managed Care. 2002;8:69–76.
    1. Gibson TB, Ozminkowski RJ, Goetzel RZ. The effects of prescription drug cost sharing: a review of the evidence. American Journal of Managed Care 11:730-40, 2005.
    1. Kaiser Family Foundation and the Health Research and Education Trust . Employer Health Benefits: 2006 Annual Survey. Washington, DC, Henry J. Kaiser Family Foundation; 2006.
    1. Pearson SA, Ross-Degnan D, Payson A, Soumerai SB. Changing medication use in managed care: a critical review of the available evidence. American Journal of Managed Care. 2003;9:715–731.
    1. Soumerai SB, McLaughlin TS, Avorn J. Improving drug prescribing in primary care: A critical analysis of the experimental literature. Milbank Q. 1989;67:268–317. doi: 10.2307/3350142.
    1. Soumerai SB, Ross-Degnan D, Fortess EE, Abelson J. A critical analysis of studies of state drug reimbursement policies: research in need of discipline. Milbank Q. 1993;71:217–252. doi: 10.2307/3350399.
    1. Freemantle N, Harvey EL, Wolf F, Grimshaw JM, Grilli R, Bero LA. Printed educational materials: effects on professional practice and health care outcomes. Cochrane Database of Systematic Reviews (2):CD000172, 2000.
    1. Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L, Grilli R, Harvey E, Oxman A, O'Brien MA. Changing provider behavior: an overview of systematic reviews of interventions. Med Care. 2001;8:II2–45.
    1. Aaserud M, Dahlgren AT, Sturm H, Kösters JP, Hill S, Furberg CD, Grilli R, Henry DA, Oxman AD, Ramsay C, Ross-Degnan D, Soumerai SB. Pharmaceutical policies: effects on rational drug use, an overview of 13 reviews (Protocol) Cochrane Database of Systematic Reviews. 2006. p. No.: CD004397.
    1. Cook TD, Campbell DT. Quasi-Experimentation: Design & Analysis Issues for Field Settings. Boston, Houghton Mifflin Company; 1979.
    1. Majumdar SR, Ross-Degnan D, Farraye FA, Lee M, Kemp JA, LeCates RF, Henning JM, Tunis SR, Schrammel P, Soumerai SB. Controlled trial of interventions to increase testing and treatment for Helicobacter pylori and reduce medication use in patients with chronic acid-related symptoms. Alimentary Pharmacology & Therapeutics. 2005;21:1029–1039. doi: 10.1111/j.1365-2036.2005.02431.x.
    1. Soumerai SB, Avorn J. Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA. 1990;263:549–556. doi: 10.1001/jama.263.4.549.
    1. Thomson O'Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database of Systematic Reviews (2):CD000409, 2000.
    1. Simon SR, Majumdar SR, Prosser LA, Salem-Schatz S, Warner C, Kleinman K, Miroshnik I, Soumerai SB. Group versus individual academic detailing to improve the use of antihypertensive medications in primary care: a cluster-randomized controlled trial. American Journal of Medicine. 2005;118:521–528. doi: 10.1016/j.amjmed.2004.12.023.
    1. Yuan Y, Hay JW, McCombs JS. Effects of ambulatory-care pharmacist consultation on mortality and hospitalization. American Journal of Managed Care. 2003;9:45–56.
    1. Stevens VJ, Shneidman RJ, Johnson RE, Boles M, Steele PE, Lee NL. Helicobacter pylori eradication in dyspeptic primary care patients: a randomized controlled trial of a pharmacy intervention. Western Journal of Medicine. 2002;176:92–96.
    1. Simon SR, Rodriguez HP, Majumdar SR, Kleinman K, Warner C, Salem-Schatz S, Miroshnik I, Soumerai SB, Prosser LA. Economic analysis of a randomized trial of academic detailing interventions to improve use of antihypertensive medications. Journal of Clinical Hypertension. 2007;9:15–20. doi: 10.1111/j.1524-6175.2007.07808.x.
    1. Lin EH, Simon GE, Katzelnick DJ, Pearson SD. Does physician education on depression management improve treatment in primary care? Journal of General Internal Medicine. 2001;16:617–619. doi: 10.1046/j.1525-1497.2001.016009614.x.
    1. Perz JF, Craig AS, Coffey CS, Jorgensen DM, Mitchel E, Hall S, Schaffner W, Griffin MR. Changes in antibiotic prescribing for children after a community-wide campaign. JAMA. 2002;287:3103–3109. doi: 10.1001/jama.287.23.3103.
    1. Jamtvedt G, Young JM, Kristoffersen DT, O'Brien MA, Oxman AD. Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database of Systematic Reviews (2):CD000259, 2006.
    1. Jamtvedt G, Young JM, Kristoffersen DT, O'Brien MA, Oxman AD. Does telling people what they have been doing change what they do? A systematic review of the effects of audit and feedback. Quality & Safety in Health Care. 2006;15:433–436. doi: 10.1136/qshc.2006.018549.
    1. Goff DC, Jr., Gu L, Cantley LK, Sheedy DJ, Cohen SJ. Quality of care for secondary prevention for patients with coronary heart disease: results of the Hastening the Effective Application of Research through Technology (HEART) trial. American Heart Journal. 2003;146:1045–1051. doi: 10.1016/S0002-8703(03)00522-2.
    1. Simon SR, Soumerai SB. Failure of Internet-based audit and feedback to improve quality of care delivered by primary care residents. International Journal for Quality in Health Care. 2005;17:427–431. doi: 10.1093/intqhc/mzi044.
    1. Gonzales R, Sauaia A, Corbett KK, Maselli JH, Erbacher K, Leeman-Castillo BA, Darr CA, Houck PM. Antibiotic treatment of acute respiratory tract infections in the elderly: effect of a multidimensional educational intervention. Journal of the American Geriatrics Society. 2004;52:39–45. doi: 10.1111/j.1532-5415.2004.52008.x.
    1. Hoffman L, Enders J, Luo J, Segal R, Pippins J, Kimberlin C. Impact of an antidepressant management program on medication adherence. American Journal of Managed Care. 2003;9:70–80.
    1. Kaushal R, Shojania KG, Bates DW. Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. [Review] Archives of Internal Medicine. 2003;163:1409–1416. doi: 10.1001/archinte.163.12.1409.
    1. Smith DH, Perrin N, Feldstein A, Yang X, Kuang D, Simon SR, Sittig DF, Platt R, Soumerai SB. The impact of prescribing safety alerts for elderly persons in an electronic medical record: an interrupted time series evaluation. Archives of Internal Medicine. 2006;166:1098–1104. doi: 10.1001/archinte.166.10.1098.
    1. Feldstein A, Elmer PJ, Smith DH, Herson M, Orwoll E, Chen C, Aickin M, Swain MC. Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial. Journal of the American Geriatrics Society. 2006;54:450–457. doi: 10.1111/j.1532-5415.2005.00618.x.
    1. Feldstein AC, Smith DH, Perrin N, Yang X, Simon SR, Krall M, Sittig DF, Ditmer D, Platt R, Soumerai SB. Reducing warfarin medication interactions: an interrupted time series evaluation. Archives of Internal Medicine. 2006;166:1009–1015. doi: 10.1001/archinte.166.9.1009.
    1. Simon SR, Smith DH, Feldstein AC, Perrin N, Yang X, Zhou Y, Platt R, Soumerai SB. Computerized prescribing alerts and group academic detailing to reduce the use of potentially inappropriate medications in older people. Journal of the American Geriatrics Society. 2006;54:963–968. doi: 10.1111/j.1532-5415.2006.00734.x.
    1. Bambauer KZ, Adams AS, Zhang F, Minkoff N, Grande A, Weisblatt R, Soumerai SB, Ross-Degnan D. Physician alerts to increase antidepressant adherence: fax or fiction? Archives of Internal Medicine. 2006;166:498–504. doi: 10.1001/archinte.166.5.498.
    1. Raebel MA, Lyons EE, Chester EA, Bodily MA, Kelleher JA, Long CL, Miller C, Magid DJ. Improving laboratory monitoring at initiation of drug therapy in ambulatory care: a randomized trial. Archives of Internal Medicine. 2005;165:2395–2401. doi: 10.1001/archinte.165.20.2395.
    1. Raebel MA, Chester EA, Newsom EE, Lyons EE, Kelleher JA, Long C, Miller C, Magid DJ. Randomized trial to improve laboratory safety monitoring of ongoing drug therapy in ambulatory patients. Pharmacotherapy. 2006;26:619–626. doi: 10.1592/phco.26.5.619.
    1. Palen TE, Raebel M, Lyons E, Magid DM. Evaluation of laboratory monitoring alerts within a computerized physician order entry system for medication orders. American Journal of Managed Care. 2006;12:389–395.
    1. Feldstein AC, Smith DH, Perrin N, Yang X, Rix M, Raebel MA, Magid DJ, Simon SR, Soumerai SB. Improved therapeutic monitoring with several interventions: a randomized trial. Archives of Internal Medicine. 2006;166:1848–1854. doi: 10.1001/archinte.166.17.1848.
    1. Rickles NM, Svarstad BL, Statz-Paynter JL, Taylor LV, Kobak KA. Pharmacist telemonitoring of antidepressant use: effects on pharmacist-patient collaboration. Journal of the American Pharmacists Association: JAPhA 45(3):344-53, 2005. Jun pp.
    1. Rickles NM, Svarstad BL, Statz-Paynter JL, Taylor LV, Kobak KA. Improving patient feedback about and outcomes with antidepressant treatment: a study in eight community pharmacies. Journal of the American Pharmacists Association: JAPhA 46(1):25-32, 2006. Feb pp.
    1. Vollmer WM, Kirshner M, Peters D, Drane A, Stibolt T, Hickey T, Tom GI, Buist AS, O'Connor EA, Frazier EA, Mosen D. Use and impact of an automated telephone outreach system for asthma in a managed care setting. American Journal of Managed Care. 2006;12:725–733.
    1. Fendrick AM, Smith DG, Chernew ME, Shah SN. A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost. American Journal of Managed Care. 2001;7:861–867.
    1. Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Frank RG. The effect of incentive-based formularies on prescription-drug utilization and spending. N Eng J Med. 2003;349:2224–2232. doi: 10.1056/NEJMsa030954.
    1. Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Muriel AC, Frank RG. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children. Archives of General Psychiatry. 2005;62:435–441. doi: 10.1001/archpsyc.62.4.435.
    1. Motheral B, Fairman KA. Effect of a three-tier prescription copay on pharmaceutical and other medical utilization. Med Care. 2001;39:1293–1304. doi: 10.1097/00005650-200112000-00005.
    1. Fairman KA, Motheral BR, Henderson RR. Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs. Clinical Therapeutics. 2003;25:3147–3161. doi: 10.1016/S0149-2918(03)90099-3.
    1. Nair KV, Wolfe P, Valuck RJ, McCollum MM, Ganther JM, Lewis SJ. Effects of a 3-tier pharmacy benefit design on the prescription purchasing behavior of individuals with chronic disease. Journal of Managed Care Pharmacy. 2003;9:123–133.
    1. Roblin DW, Platt R, Goodman MJ, Hsu J, Nelson WW, Smith DH, Andrade SE, Soumerai SB. Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much? Med Care. 2005;43:951–959. doi: 10.1097/01.mlr.0000178216.23514.b7.
    1. MacKinnon NJ, Kumar R. Prior authorization programs: a critical review of the literature. Journal of Managed Care Pharm. 2001;7:297–302.
    1. Hartung DM, Touchette DR, Ketchum KL, Haxby DG, Goldberg BW. Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicaid population. Clinical Therapeutics. 2004;26:1518–1532. doi: 10.1016/j.clinthera.2004.09.013.
    1. Gleason PP, Williams C, Hrdy S, Hartwig SC, Lassen D. Medical and pharmacy expenditures after implementation of a cyclooxygenase-2 inhibitor prior authorization program. Pharmacotherapy. 2005;25:924–934. doi: 10.1592/phco.2005.25.7.924.
    1. Gurwitz JH, McLaughlin TJ, Fish LS. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products. Health Serv Res. 1995;30:672–685.
    1. McDonough KP, Weaver RH, Viall GD. Enalapril to lisinopril: economic impact of a voluntary angiotensin-converting enzyme-inhibitor substitution program in a staff-model health maintenance organization. Ann Pharmacother. 1992;26:399–404.
    1. Andrade SE, Gurwitz JH, Cernieux J, Fish LS. Evaluation of a formulary switch from conjugated to esterified estrogens in a managed care setting. Med Care. 2000;38:970–975. doi: 10.1097/00005650-200009000-00010.
    1. Sullivan PW, Nair KV, Patel BV. The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy. American Journal of Managed Care. 2005;11:374–382.
    1. Delate T, Fairman KA, Carey SM, Motheral BR. Randomized controlled trial of a dose consolidation program. Journal of Managed Care Pharmacy. 2004;10:396–403.
    1. Delate T, Henderson R. Effect of patient notification of formulary change on formulary adherence. Journal of Managed Care Pharmacy. 2005;11:493–498.
    1. DeZearn K, Springer S, Benson D, Stephens C. Promoting use of a preferred histamine H2-receptor antagonist in managed care organizations. Am J Health Syst Pharm. 1996;53:865–867.
    1. Gilbody S, Bower P, Fletcher J, Richards D, Sutton AJ. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Archives of Internal Medicine. 2006;166:2314–2321. doi: 10.1001/archinte.166.21.2314.
    1. Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, Lee JY, Bero LA. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy. 2003;23:1175–1185. doi: 10.1592/phco.23.10.1175.32760.
    1. Okamoto MP, Nakahiro RK. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Pharmacotherapy. 2001;21:1337–1344. doi: 10.1592/phco.21.17.1337.34424.
    1. Rehring TF, Stolcpart RS, Sandhoff BG, Merenich JA, Hollis HW., Jr. Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial disease. Journal of Vascular Surgery. 2006;43:1205–1210. doi: 10.1016/j.jvs.2006.02.019.
    1. Straka RJ, Taheri R, Cooper SL, Smith JC. Achieving cholesterol target in a managed care organization (ACTION) trial. Pharmacotherapy. 2005;25:360–371. doi: 10.1592/phco.25.3.360.61601.
    1. Borenstein JE, Graber G, Saltiel E, Wallace J, Ryu S, Archi J, Deutsch S, Weingarten SR. Physician-pharmacist comanagement of hypertension: a randomized, comparative trial. Pharmacotherapy. 2003;23:209–216. doi: 10.1592/phco.23.2.209.32096.
    1. Bodenheimer T. Disease management in the American market. BMJ. 2000;320:563–566. doi: 10.1136/bmj.320.7234.563.
    1. Badamgarav E, Weingarten SR, Henning JM, Knight K, Hasselblad V, Gano A, Jr., Ofman JJ. Effectiveness of disease management programs in depression: a systematic review. American Journal of Psychiatry. 2003;160:2080–2090. doi: 10.1176/appi.ajp.160.12.2080.
    1. Panzarino PJ., Jr. The costs of depression: direct and indirect; treatment versus nontreatment. [Review] Journal of Clinical Psychiatry. 1920;59:11–14.
    1. Katon W, Russo J, Von Korff M, Lin E, Simon G, Bush T, Ludman E, Walker E. Long-term effects of a collaborative care intervention in persistently depressed primary care patients. Journal of General Internal Medicine. 2002;17:741–748. doi: 10.1046/j.1525-1497.2002.11051.x.
    1. Katon WJ, Von Korff M, Lin EH, Simon G, Ludman E, Russo J, Ciechanowski P, Walker E, Bush T. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Archives of General Psychiatry. 2004;61:1042–1049. doi: 10.1001/archpsyc.61.10.1042.
    1. Unutzer J, Rubenstein L, Katon WJ, Tang L, Duan N, Lagomasino IT, Wells KB. Two-year effects of quality improvement programs on medication management for depression. Archives of General Psychiatry. 2001;58:935–942. doi: 10.1001/archpsyc.58.10.935.
    1. Ray WA, Daugherty JR, Meador KG. Effect of a mental health "carve-out" program on the continuity of antipsychotic therapy. N Eng J Med. 2003;348:1885–1894. doi: 10.1056/NEJMsa020584.
    1. Lozano P, Finkelstein JA, Carey VJ, Wagner EH, Inui TS, Fuhlbrigge AL, Soumerai SB, Sullivan SD, Weiss ST, Weiss KB. A multisite randomized trial of the effects of physician education and organizational change in chronic-asthma care: health outcomes of the Pediatric Asthma Care Patient Outcomes Research Team II Study. Archives of Pediatrics & Adolescent Medicine. 2004;158:875–883. doi: 10.1001/archpedi.158.9.875.
    1. Finkelstein JA, Lozano P, Fuhlbrigge AL, Carey VJ, Inui TS, Soumerai SB, Sullivan SD, Wagner EH, Weiss ST, Weiss KB, Pediatric Asthma Care Patient Outcomes Research Team Practice-level effects of interventions to improve asthma care in primary care settings: the Pediatric Asthma Care Patient Outcomes Research Team. Health Serv Res. 2005;40:1737–1757. doi: 10.1111/j.1475-6773.2005.00451.x.
    1. Peterson WL, Fendrick AM, Cave DR, Peura DA, Garabedian-Ruffalo SM, Laine L. Helicobacter pylori-related disease: guidelines for testing and treatment. Archives of Internal Medicine. 2000;160:1285–1291. doi: 10.1001/archinte.160.9.1285.
    1. Soll AH. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology.[erratum appears in JAMA 1996 May 1;275(17):1314] JAMA. 1996;275:622–629. doi: 10.1001/jama.275.8.622.
    1. Allison JE, Hurley LB, Hiatt RA, Levin TR, Ackerson LM, Lieu TA. A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease. Archives of Internal Medicine. 2003;163:1165–1171. doi: 10.1001/archinte.163.10.1165.
    1. Ofman JJ, Segal R, Russell WL, Cook DJ, Sandhu M, Maue SK, Lowenstein EH, Pourfarzib R, Blanchette E, Ellrodt G, Weingarten SR. A randomized trial of an acid-peptic disease management program in a managed care environment. American Journal of Managed Care 9(6):425-33, 2003.
    1. Osterberg L, Blaschke T. Adherence to medication. New England Journal of Medicine 353(5):487-97, 2005.
    1. Arnold SR, Straus SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database of Systematic Reviews (4):CD003539, 2005.
    1. Thomson O'Brien MA, Oxman AD, Haynes RB, Davis DA, Freemantle N, Harvey EL. Local opinion leaders: effects on professional practice and health care outcomes. [Review] Cochrane Database of Systematic Reviews (2):CD000125, 2000.
    1. Simon GE, VonKorff M, Rutter C, Wagner E. Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. BMJ. 2000;320:550–554. doi: 10.1136/bmj.320.7234.550.
    1. Kawamoto K, Houlihan CA, Balas EA, Lobach DF. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. [Review] BMJ. 2005;330:765. doi: 10.1136/bmj.38398.500764.8F.
    1. Gleason PP, Gunderson BW, Gericke KR. Are incentive-based formularies inversely associated with drug utilization in managed care? Ann Pharmacother. 2005;39:339–345. doi: 10.1345/aph.1E380.
    1. Soumerai SB. Benefits and risks of increasing restrictions on access to costly drugs in Medicaid. Health Affairs. 2004;23:135–146. doi: 10.1377/hlthaff.23.1.135.
    1. Finley PR, Crismon ML, Rush AJ. Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy. 2003;23:1634–1644. doi: 10.1592/phco.23.15.1634.31952.
    1. Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. [Review] Archives of Internal Medicine. 2006;166:955–964. doi: 10.1001/archinte.166.9.955.
    1. Vergouwen AC, Bakker A, Katon WJ, Verheij TJ, Koerselman F. Improving adherence to antidepressants: a systematic review of interventions. [Review] Journal of Clinical Psychiatry. 2003;64:1415–1420.
    1. Weingarten SR, Henning JM, Badamgarav E, Knight K, Hasselblad V, Gano A, Jr., Ofman JJ. Interventions used in disease management programmes for patients with chronic illness-which ones work? Meta-analysis of published reports.[Review] BMJ. 2002;325:925. doi: 10.1136/bmj.325.7370.925.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren